Wang Zhuang, Heid Bettina, Lu Ran, Sachdeva Mohit, Edwards Michael R, Ren JingJing, Cecere Thomas E, Khan Deena, Jeboda Taschua, Kirsch David G, Reilly Christopher M, Dai Rujuan, Ahmed S Ansar
Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine (VMCVM), Virginia Tech, Blacksburg, VA, United States.
Preclinical Lead Immunology, Spark Theraprutics, Philadelphia, PA, United States.
Front Genet. 2022 Jul 7;13:840060. doi: 10.3389/fgene.2022.840060. eCollection 2022.
Dysregulated miRNAs have been implicated in the pathogenesis of systemic lupus erythematosus (SLE). Our previous study reported a substantial increase in three miRNAs located at the miR-183-96-182 cluster (miR-183C) in several autoimmune lupus-prone mice, including MRL/lpr and C57BL/6-lpr (B6/lpr). This study reports that inhibition of miR-182 alone or miR-183C by specific antagomirs in activated splenocytes from autoimmune-prone MRL/lpr and control MRL mice significantly reduced lupus-related inflammatory cytokines, interferon-gamma (IFNγ), and IL-6 production. To further characterize the role of miR-182 and miR-183C cluster in lupus-like disease and lymphocyte phenotypes, we used hCD2-iCre to generate B6/lpr mice with conditional deletion of miR-182 or miR-183C in CD2 lymphocytes (miR-182B6/lpr and miR-183CB6/lpr). The miR-182B6/lpr and miR-183CB6/lpr mice had significantly reduced deposition of IgG immunocomplexes in the kidney when compared to their respective littermate controls, although there appeared to be no remarkable changes in renal pathology. Importantly, we observed a significant reduction of serum anti-dsDNA autoantibodies in miR-183CB6/lpr mice after reaching 24 weeks-of age compared to age-matched miR-183CB6/lpr controls. activated splenocytes from miR-182B6/lpr mice and miR-183CB6/lpr mice showed reduced ability to produce lupus-associated IFNγ. Forkhead box O1(Foxo1), a previously validated miR-183C miRNAs target, was increased in the splenic CD4 cells of miR-182B6/lpr and miR-183CB6/lpr mice. Furthermore, inhibition of Foxo1 with siRNA in splenocytes from miR-182B6/lpr and miR-183CB6/lpr mice significantly increased IFNγ expression following anti-CD3/CD28 stimulation, suggesting that miR-182 and miR-183C miRNAs regulate the inflammatory IFNγ in splenocytes via targeting Foxo1. The deletion of either miR-182 alone or the whole miR-183C cluster, however, had no marked effect on the composition of T and B cell subsets in the spleens of B6/lpr mice. There were similar percentages of CD4, CD8, CD19, as well as Tregs, follicular helper T (T), germinal center B (GCB), and plasma cells in the miR-183CB6/lpr and miR-182B6/lpr mice and their respective littermate controls, miR-183CB6/lpr and miR-182B6/lpr mice. Together, our data demonstrate a role of miR-183C in the regulation of anti-dsDNA autoantibody production in B6/lpr mice and the induction of IFNγ in activated splenocytes from B6/lpr mice.
失调的微小RNA(miRNA)与系统性红斑狼疮(SLE)的发病机制有关。我们之前的研究报道,在几种自身免疫性狼疮易感小鼠,包括MRL/lpr和C57BL/6-lpr(B6/lpr)中,位于miR-183-96-182簇(miR-183C)的三种miRNA大幅增加。本研究报道,在自身免疫易感的MRL/lpr小鼠和对照MRL小鼠活化的脾细胞中,用特异性抗miR-182或抗miR-183C抑制miR-182或miR-183C单独或miR-183C显著降低了狼疮相关炎性细胞因子、干扰素-γ(IFNγ)和IL-6的产生。为了进一步阐明miR-182和miR-183C簇在狼疮样疾病和淋巴细胞表型中的作用,我们使用hCD2-iCre在CD2淋巴细胞中条件性缺失miR-182或miR-183C,从而产生B6/lpr小鼠(miR-182B6/lpr和miR-183CB6/lpr)。与各自的同窝对照相比,miR-182B6/lpr和miR-183CB6/lpr小鼠肾脏中IgG免疫复合物的沉积显著减少,尽管肾脏病理学似乎没有明显变化。重要的是,与年龄匹配的miR-183CB6/lpr对照相比,我们观察到miR-183CB6/lpr小鼠在24周龄后血清抗双链DNA自身抗体显著减少。miR-182B6/lpr小鼠和miR-183CB6/lpr小鼠活化的脾细胞产生狼疮相关IFNγ的能力降低。叉头框O1(Foxo1)是先前已验证的miR-183C miRNAs靶点,在miR-182B6/lpr和miR-183CB6/lpr小鼠的脾脏CD4细胞中增加。此外,用小干扰RNA(siRNA)抑制miR-182B6/lpr和miR-183CB6/lpr小鼠脾细胞中的Foxo1,在抗CD3/CD28刺激后显著增加IFNγ表达,表明miR-182和miR-183C miRNAs通过靶向Foxo1调节脾细胞中的炎性IFNγ。然而,单独缺失miR-182或整个miR-183C簇对B6/lpr小鼠脾脏中T和B细胞亚群的组成没有显著影响。miR-183CB6/lpr和miR-182B6/lpr小鼠及其各自的同窝对照miR-183CB6/lpr和miR-182B6/lpr小鼠中CD4、CD8、CD19以及调节性T细胞(Tregs)、滤泡辅助性T细胞(Tfh)、生发中心B细胞(GCB)和浆细胞的百分比相似。总之,我们的数据证明了miR-183C在调节B6/lpr小鼠抗双链DNA自身抗体产生以及诱导B6/lpr小鼠活化脾细胞中IFNγ方面的作用。